b7446429-nogoingback-logo-01_10w6082000000000000028

For the patients we pledge to serve, there is #NoGoingBack

As an industry, we learned bold new ways to conduct trials due to COVID-19. Now that we have seen the future so clearly, there is no going back. Whether you work at a sponsor, site, provider, advocacy group or other healthcare organization, please join in the mission to keep trials moving forward.

1-Apr-24-2025-03-06-53-3840-PM

We can adapt faster than we thought we could

2-Apr-24-2025-03-06-53-3785-PM

Collaboration between "competitors" is needed to accelerate progress

3-Apr-24-2025-03-06-53-4143-PM

Our industry has an unparalleled opportunity to make huge improvements in drug development

4-Apr-24-2025-03-06-53-4076-PM

Patients deserve and want flexible options for trial participation

WE WILL maintain the momentum we gained from new ideas, partnerships, and technology that help us advance life-changing treatments faster

WE WILL keep moving forward and never be satisfied with going back to trial conduct of the past

WE WILL share this charter with colleagues and peers, and encourage them to apply these principles to preserve the progress we've made in clinical trials

Amid all the uncertainty, one thing is clear - there is #NoGoingBack.

EM-2025-02-Vaccine-RTSM-Email-Hero

Chairpersons

Craig-Lipset
Craig Lipset
Advisor & Founder
Clinical Innovation Partners
Allyson-Small
Allyson Small
Chief Operating Officer
SCRS
Scott-Connor
Scott Connor
Chief Marketing Officer
Signant Health
Maimah-Karmo
Maimah Karmo
President & CEO
Tigerlily Foundation
Sung-Poblete
Sung Poblete
Chief Executive Officer
Stand Up To Cancer

Signatories

ngb

b7446429-nogoingback-logo-01_10w6082000000000000028

For the patients we pledge to serve,
there is only one choice.